Dan Worthley owns shares in GenCirq, a synthetic biology company focussed on cancer therapeutics. This work was supported by an NHMRC ideas grant (2020555) awarded to Dan Worthley. Dan Worthley is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback